Q5149 Injection, aflibercept-abzv, 1 milligrams
Q-Codes
Also known as: aflibercept biosimilar, Yannuzay, anti-VEGF, VEGF inhibitor
Injection of aflibercept-abzv (Yannuzay), a biosimilar to aflibercept, administered at 1 milligram per dose.
Clinical Context
Used for neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion. Administered by intravitreal injection as maintenance therapy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.